Matches in SemOpenAlex for { <https://semopenalex.org/work/W2794015746> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W2794015746 abstract "191 Background: Most immune checkpoint inhibitors have shown limited efficacy in unselected men with mPC, and there is limited understanding about which immune checkpoints (ICs) are relevant in mPC. We evaluated ICs on the cell surface of circulating tumor cells (CTCs) in patients with mPC. Methods: Patients were enrolled prospectively at the Duke Cancer Center in three cohorts: A) mCRPC starting the novel androgen receptor inhibitors abiraterone acetate (AA) or enza with or without sipuleucel-T, B) mCRPC with disease progression after AA or enza, and C) metastatic castration sensitive PC. The Cellsearch platform was used to capture EpCAM- and CK-expressing CTCs and analyzed for PD-L1, PD-L2, B7-H3, and CTLA-4 expression at baseline, 12 weeks, and at further disease progression. Results: Through August 2017, we enrolled 4 subjects in cohort A, 7 in cohort B, and 3 in cohort C. CTCs were detectable in every cohort. At baseline, B7-H3 was the most prevalent IC on a per-patient basis (mean 96% in cohort A, and 100% in cohort B, and 88% in cohort C). PD-L1 was detected less frequently (cohort A mean 8%, cohort B mean 42%, and cohort C mean 67%), with evidence of heterogeneity of CTC PD-L1 expression between and within patients. PD-L1 was expressed on 8% of CTCs in cohort C and cohort A, as compared to 28% of CTCs in cohort B, while CTLA-4 expression was not identified in cohort C, 3% of cohort A, and 15% of cohort B. B7H3 was expressed on 68% of cohort C, 91% of cohort A, and 98% of cohort B. PD-L2 was expressed on 0-7% of CTCs overall. Conclusions: Patients with mPC can have detectable and heterogeneous ICs on CTCs, particularly PD-L1 and B7-H3, and these characteristics can be monitored over time. B7-H3 was the most prevalent IC on CTCs, regardless of disease state. Our preliminary data suggests that men with mCRPC post-enza/AA have higher levels of PD-L1 and CTLA-4 expression on their CTCs as compared with men with mHSPC and mCRPC prior to enza/AA. Patient enrollment and analysis are ongoing." @default.
- W2794015746 created "2018-03-29" @default.
- W2794015746 creator A5005547611 @default.
- W2794015746 creator A5020223699 @default.
- W2794015746 creator A5033138240 @default.
- W2794015746 creator A5033510051 @default.
- W2794015746 creator A5033835226 @default.
- W2794015746 creator A5038489185 @default.
- W2794015746 creator A5051354199 @default.
- W2794015746 creator A5052344423 @default.
- W2794015746 creator A5061638510 @default.
- W2794015746 creator A5061888417 @default.
- W2794015746 creator A5062117905 @default.
- W2794015746 creator A5083989898 @default.
- W2794015746 date "2018-02-20" @default.
- W2794015746 modified "2023-09-23" @default.
- W2794015746 title "Expression of immune checkpoints on circulating tumor cells in men with metastatic prostate cancer (mPC)." @default.
- W2794015746 doi "https://doi.org/10.1200/jco.2018.36.6_suppl.191" @default.
- W2794015746 hasPublicationYear "2018" @default.
- W2794015746 type Work @default.
- W2794015746 sameAs 2794015746 @default.
- W2794015746 citedByCount "0" @default.
- W2794015746 crossrefType "journal-article" @default.
- W2794015746 hasAuthorship W2794015746A5005547611 @default.
- W2794015746 hasAuthorship W2794015746A5020223699 @default.
- W2794015746 hasAuthorship W2794015746A5033138240 @default.
- W2794015746 hasAuthorship W2794015746A5033510051 @default.
- W2794015746 hasAuthorship W2794015746A5033835226 @default.
- W2794015746 hasAuthorship W2794015746A5038489185 @default.
- W2794015746 hasAuthorship W2794015746A5051354199 @default.
- W2794015746 hasAuthorship W2794015746A5052344423 @default.
- W2794015746 hasAuthorship W2794015746A5061638510 @default.
- W2794015746 hasAuthorship W2794015746A5061888417 @default.
- W2794015746 hasAuthorship W2794015746A5062117905 @default.
- W2794015746 hasAuthorship W2794015746A5083989898 @default.
- W2794015746 hasConcept C121608353 @default.
- W2794015746 hasConcept C126322002 @default.
- W2794015746 hasConcept C143998085 @default.
- W2794015746 hasConcept C203014093 @default.
- W2794015746 hasConcept C2775832370 @default.
- W2794015746 hasConcept C2776551883 @default.
- W2794015746 hasConcept C2777899217 @default.
- W2794015746 hasConcept C2779013556 @default.
- W2794015746 hasConcept C2780192828 @default.
- W2794015746 hasConcept C61238886 @default.
- W2794015746 hasConcept C61367390 @default.
- W2794015746 hasConcept C71924100 @default.
- W2794015746 hasConcept C72563966 @default.
- W2794015746 hasConcept C8891405 @default.
- W2794015746 hasConceptScore W2794015746C121608353 @default.
- W2794015746 hasConceptScore W2794015746C126322002 @default.
- W2794015746 hasConceptScore W2794015746C143998085 @default.
- W2794015746 hasConceptScore W2794015746C203014093 @default.
- W2794015746 hasConceptScore W2794015746C2775832370 @default.
- W2794015746 hasConceptScore W2794015746C2776551883 @default.
- W2794015746 hasConceptScore W2794015746C2777899217 @default.
- W2794015746 hasConceptScore W2794015746C2779013556 @default.
- W2794015746 hasConceptScore W2794015746C2780192828 @default.
- W2794015746 hasConceptScore W2794015746C61238886 @default.
- W2794015746 hasConceptScore W2794015746C61367390 @default.
- W2794015746 hasConceptScore W2794015746C71924100 @default.
- W2794015746 hasConceptScore W2794015746C72563966 @default.
- W2794015746 hasConceptScore W2794015746C8891405 @default.
- W2794015746 hasLocation W27940157461 @default.
- W2794015746 hasOpenAccess W2794015746 @default.
- W2794015746 hasPrimaryLocation W27940157461 @default.
- W2794015746 hasRelatedWork W2039129728 @default.
- W2794015746 hasRelatedWork W2330426056 @default.
- W2794015746 hasRelatedWork W2590255260 @default.
- W2794015746 hasRelatedWork W2601851132 @default.
- W2794015746 hasRelatedWork W2605219687 @default.
- W2794015746 hasRelatedWork W2755595775 @default.
- W2794015746 hasRelatedWork W2794223852 @default.
- W2794015746 hasRelatedWork W2909590671 @default.
- W2794015746 hasRelatedWork W2957574365 @default.
- W2794015746 hasRelatedWork W2991577674 @default.
- W2794015746 hasRelatedWork W3013885934 @default.
- W2794015746 hasRelatedWork W3022229928 @default.
- W2794015746 hasRelatedWork W3038718086 @default.
- W2794015746 hasRelatedWork W3083018500 @default.
- W2794015746 hasRelatedWork W3104014735 @default.
- W2794015746 hasRelatedWork W3106755805 @default.
- W2794015746 hasRelatedWork W3131880121 @default.
- W2794015746 hasRelatedWork W3160412535 @default.
- W2794015746 hasRelatedWork W3164103726 @default.
- W2794015746 hasRelatedWork W3206647534 @default.
- W2794015746 isParatext "false" @default.
- W2794015746 isRetracted "false" @default.
- W2794015746 magId "2794015746" @default.
- W2794015746 workType "article" @default.